A new report by MyHome and the Bank of Ireland suggests the Irish economy’s dependence on U.S. multinationals could lead to a ...

Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, ...

Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

By Sabrina Valle NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives ...

Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.